<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 27 May 2026 06:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration</title>
   <link>http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint.

&lt;/p&gt;&lt;p&gt;
“Registering our medical cannabis operations with the DEA marks a significant</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html</guid>
   <pubDate>Wed, 27 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.37042239</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21062042</category>
   	  </item>
  <item>
   <title>Canaccord Upgrades Cresco Labs Inc. (CL:CN) (CRLBF) to Buy</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</link>
   <description>&lt;p&gt;Canaccord analyst Luke Hannan upgraded Cresco Labs Inc. (CL:CN) (OTC: CRLBF) from Spec. Buy to Buy with a price target of Cdn$2.50 (from Cdn$2.25).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</guid>
   <pubDate>Mon, 11 May 2026 07:20:02 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	  </item>
  <item>
   <title>Canaccord Upgrades Cresco Labs Inc. (CL:CN) (CRLBF) to Buy</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</link>
   <description>&lt;p&gt;Canaccord analyst Luke Hannan upgraded Cresco Labs Inc. (CL:CN) (OTC: CRLBF) from Spec. Buy to Buy with a price target of Cdn$2.50 (from Cdn$2.25).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</guid>
   <pubDate>Mon, 11 May 2026 07:20:02 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	  </item>
  <item>
   <title>Canaccord Upgrades Cresco Labs Inc. (CL:CN) (CRLBF) to Buy</title>
   <link>http://www.streetinsider.com/Upgrades/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</link>
   <description>&lt;p&gt;Canaccord analyst Luke Hannan upgraded Cresco Labs Inc. (CL:CN) (OTC: CRLBF) from Spec. Buy to Buy with a price target of Cdn$2.50 (from Cdn$2.25).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</guid>
   <pubDate>Mon, 11 May 2026 07:20:02 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	  </item>
  <item>
   <title>Canaccord Upgrades Cresco Labs Inc. (CL:CN) (CRLBF) to Buy</title>
   <link>http://www.streetinsider.com/Upgrades/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</link>
   <description>&lt;p&gt;Canaccord analyst Luke Hannan upgraded Cresco Labs Inc. (CL:CN) (OTC: CRLBF) from Spec. Buy to Buy with a price target of Cdn$2.50 (from Cdn$2.25).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</guid>
   <pubDate>Mon, 11 May 2026 07:20:02 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	  </item>
  <item>
   <title>Canaccord Upgrades Cresco Labs Inc. (CL:CN) (CRLBF) to Buy</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</link>
   <description>&lt;p&gt;Canaccord analyst Luke Hannan upgraded Cresco Labs Inc. (CL:CN) (OTC: CRLBF) from Spec. Buy to Buy with a price target of Cdn$2.50 (from Cdn$2.25).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</guid>
   <pubDate>Mon, 11 May 2026 07:20:02 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	  </item>
  <item>
   <title>Canaccord Upgrades Cresco Labs Inc. (CL:CN) (CRLBF) to Buy</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</link>
   <description>&lt;p&gt;Canaccord analyst Luke Hannan upgraded Cresco Labs Inc. (CL:CN) (OTC: CRLBF) from Spec. Buy to Buy with a price target of Cdn$2.50 (from Cdn$2.25).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Canaccord+Upgrades+Cresco+Labs+Inc.+%28CL%3ACN%29+%28CRLBF%29+to+Buy/26465002.html</guid>
   <pubDate>Mon, 11 May 2026 07:20:02 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	  </item>
  <item>
   <title>Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;amp;esheet=54533181&amp;amp;newsitemid=20260511242350&amp;amp;lan=en-US&amp;amp;anchor=has+announced&amp;amp;index=1&amp;amp;md5=bbc391008eb8494b938404eaf565c085&quot; shape=&quot;rect&quot;&gt;has announced&lt;/a&gt; a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</guid>
   <pubDate>Mon, 11 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	  </item>
  <item>
   <title>Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;amp;esheet=54533181&amp;amp;newsitemid=20260511242350&amp;amp;lan=en-US&amp;amp;anchor=has+announced&amp;amp;index=1&amp;amp;md5=bbc391008eb8494b938404eaf565c085&quot; shape=&quot;rect&quot;&gt;has announced&lt;/a&gt; a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</guid>
   <pubDate>Mon, 11 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	  </item>
  <item>
   <title>Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;amp;esheet=54533181&amp;amp;newsitemid=20260511242350&amp;amp;lan=en-US&amp;amp;anchor=has+announced&amp;amp;index=1&amp;amp;md5=bbc391008eb8494b938404eaf565c085&quot; shape=&quot;rect&quot;&gt;has announced&lt;/a&gt; a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</guid>
   <pubDate>Mon, 11 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	  </item>
  <item>
   <title>Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;amp;esheet=54533181&amp;amp;newsitemid=20260511242350&amp;amp;lan=en-US&amp;amp;anchor=has+announced&amp;amp;index=1&amp;amp;md5=bbc391008eb8494b938404eaf565c085&quot; shape=&quot;rect&quot;&gt;has announced&lt;/a&gt; a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</guid>
   <pubDate>Mon, 11 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	  </item>
  <item>
   <title>Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety</title>
   <link>http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</link>
   <description>
&lt;p&gt;    CHICAGO--(BUSINESS WIRE)--
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;amp;esheet=54533181&amp;amp;newsitemid=20260511242350&amp;amp;lan=en-US&amp;amp;anchor=has+announced&amp;amp;index=1&amp;amp;md5=bbc391008eb8494b938404eaf565c085&quot; shape=&quot;rect&quot;&gt;has announced&lt;/a&gt; a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html</guid>
   <pubDate>Mon, 11 May 2026 06:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">6CQ</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CRLBF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02619105</category>
   	  </item>
 </channel>
</rss>
